Boston Family Office’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35,181
Closed -$5.15M 322
2025
Q3
$5.15M Buy
35,181
+766
+2% +$116K 0.33% 72
2025
Q2
$5.37M Buy
34,415
+1,152
+3% +$183K 0.36% 67
2025
Q1
$5.48M Buy
33,263
+5,735
+21% +$954K 0.39% 65
2024
Q4
$4.49M Sell
27,528
-6,365
-19% -$1.14M 0.31% 72
2024
Q3
$6.62M Buy
+33,893
New +$6.24M 0.45% 60
2013
Q4
Sell
-11,075
Closed -$345K 259
2013
Q3
$345K Buy
11,075
+100
+0.9% +$3.06K 0.05% 218
2013
Q2
$339K Buy
+10,975
New +$355K 0.05% 206

Other funds holding ZTS

Boston Family Office's ZTS Position: Q4 2025 in Review

Boston Family Office sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 35,181 shares — an estimated $5.15M sold.

Boston Family Office first reported a position in ZTS in Q2 2013 and held it in 7 quarters. The position peaked at $6.62M in Q3 2024. 1,680 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • Boston Family Office reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • Boston Family Office sold 35,181 Zoetis shares in Q4 2025, an estimated $5.15M.
  • Boston Family Office first reported a position in Zoetis in Q2 2013 and held it in 7 quarters.
  • Boston Family Office's Zoetis position peaked at $6.62M in Q3 2024.
  • 1,680 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Boston Family Office's 13F filing for Q4 2025, filed 13 Feb 2026.